Edition:
United Kingdom

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

11.11USD
15 Dec 2017
Change (% chg)

$-0.08 (-0.71%)
Prev Close
$11.19
Open
$11.32
Day's High
$11.40
Day's Low
$11.07
Volume
3,125
Avg. Vol
9,978
52-wk High
$14.52
52-wk Low
$7.30

Latest Key Developments (Source: Significant Developments)

Alpine Immune Sciences qtrly earnings per share ‍$0.18​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Alpine Immune Sciences Inc ::Alpine Immune Sciences reports corporate update and third quarter 2017 financial results.Q3 revenue $100,000 versus $700,000.Alpine Immune Sciences Inc - ‍company expects to have cash to fund operations into 2020​.Alpine Immune Sciences Inc qtrly earnings per share ‍$0.18​.  Full Article

Nivalis Q2 loss per share $0.55
Monday, 1 Aug 2016 

Nivalis Therapeutics Inc : Q2 loss per share $0.55 . Nivalis therapeutics reports second quarter 2016 financial results .Q2 earnings per share view $-0.52 -- Thomson Reuters I/B/E/S.  Full Article

Nivalis Therapeutics files for mixed shelf of up to $142.5 mln - SEC filing
Wednesday, 6 Jul 2016 

Nivalis Therapeutics Inc : Says files for mixed shelf of up to $142.5 million - SEC filing Source:(http://bit.ly/29xPQCz ) Further company coverage: [NVLS.O] (Bengaluru Newsroom: +1 646 223 8780).  Full Article

Nivalis Therapeutics, Inc reports FDA fast track designation for n91115
Thursday, 18 Feb 2016 

Nivalis Therapeutics, Inc:Announces FDA fast track designation for n91115 in patients with cystic fibrosis.Says company expects data from this trial in the second half of 2016.  Full Article

BRIEF-Alpine Immune Sciences qtrly earnings per share ‍$0.18​

* Alpine Immune Sciences reports corporate update and third quarter 2017 financial results